Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical QuIpazInmaleate 50mg
SDP

Catalog No. 502944034
Encompass_Preferred

A 5-HT2A, 5-HT2B, and 5-HT2C receptor agonist; induces calcium accumulation in CHO-K1 cells expressing 5-HT2A, 5-HT2B, or 5-HT2C receptors (EC50s = 309.03, 177.83, and 338.84 nM, respectively, for the human receptors); binds to the 5-HT3 receptor (Ki = 2.1 nM); decreases food intake in rats at 2.5, 5, or 10 mg/kg; restores spinal circuitry function, improves gait regularity, and increases interlimb coordination and limb weight-bearing in a rat model of spinal cord transection-induced hindlimb paralysis at 0.3 mg/kg per day in combination with 8-hydroxy DPAT, electrode stimulation of dorsal and lumbar spine regions, and locomotor training

Catalog No. 50-294-4034 Supplier Cayman Chemical Supplier No. 4226250 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

A 5-HT2A, 5-HT2B, and 5-HT2C receptor agonist; induces calcium accumulation in CHO-K1 cells expressing 5-HT2A, 5-HT2B, or 5-HT2C receptors (EC50s = 309.03, 177.83, and 338.84 nM, respectively, for the human receptors); binds to the 5-HT3 receptor (Ki = 2.1 nM); decreases food intake in rats at 2.5, 5, or 10 mg/kg; restores spinal circuitry function, improves gait regularity, and increases interlimb coordination and limb weight-bearing in a rat model of spinal cord transection-induced hindlimb paralysis at 0.3 mg/kg per day in combination with 8-hydroxy DPAT, electrode stimulation of dorsal and lumbar spine regions, and locomotor training

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.